- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05781620
Vitamin D Supplementation in Healthy Adults in Prolonged Endurance Exercise
December 18, 2023 updated by: Taipei Medical University
Effects of Vitamin D Supplementation on Biochemical Reaction and Skeletal Muscle Synthesis in Prolonged Endurance Exercise and Cluster Set Configurations of Resistance Training
The purpose of this study is to investigate the effects of vitamin D supplementation on biochemistry response and skeletal muscle synthesis in prolonged endurance exercise.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
Endurance exercise mode will be used to evaluate the effects of vitamin D supplementation on cardiac biomarkers, metabolic hormones, oxidative damage, and inflammation responses.
An independent samples and dose titration design will be used to assign 30 participants to the experimental group (n = 15) or placebo group (n = 15).
All participants in the experimental group will have serum 25(OH)D concentrations higher than 48 ng/mL after supplementation period.
After the prolonged endurance exercise test, the blood samples will be collected for analyzing biomarkers.
Data will be analyzed by Two-way mixed design ANOVA.
Study Type
Interventional
Enrollment (Estimated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 110
- Taipei Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion criteria:
The volunteers included have conditions as stated below :
- male adult between 20-40 years old without any history of cardiovascular, liver, kidney and diabetes disease
- no acute sport injury
- male adult whose concentration of 25(OH)D is under 30 ng/mL, and maximal oxygen consumption is over 40 ml/kg/min
- did not participated in any clinical trials or research in the last 3 months before our experiment
- no supplements were taken during the experimental period
- were requested to maintain their regular daily life style and avoid alcohol intake
Exclusion Criteria:
The volunteers were excluded if they have the situation stated below:
- history of cardiovascular, liver, kidney and diabetes disease
- acute sport injury
- their concentration of 25(OH)D is over 30 ng/mL, or maximal oxygen consumption is under 40 ml/kg/mint
- participated in any clinical trials or experimental research in the last 3 months before our experiment
- taking supplement during the experimental period
- did not maintain their regular eating habit or drink alcohol
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo group
|
Participants received the same amount of placebo matching vitamin D orally twice daily.
|
|
Experimental: Vitamin D group
|
Participants received 5,000 IU of vitamin D orally twice daily for 4 weeks.
If the serum 25(OH)D concentration exceeds 48 ng/mL, the intervention remains the same.
However, if the serum 25(OH)D concentration is under 48 ng/mL, the dosage would increase by 2,500 IU.
The principle remains the same at week 6.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Concentration of leukocyte
Time Frame: before exercise
|
before exercise
|
|
Concentration of leukocyte
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of leukocyte
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of leukocyte
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of neutrophil
Time Frame: before exercise
|
before exercise
|
|
Concentration of neutrophil
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of neutrophil
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of neutrophil
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of lymphocyte
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of lymphocyte
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of lymphocyte
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of CD4+
Time Frame: before exercise
|
before exercise
|
|
Concentration of CD4+
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of CD4+
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of CD4+
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of CD8+
Time Frame: before exercise
|
before exercise
|
|
Concentration of CD8+
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of CD8+
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of CD8+
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of CD19+
Time Frame: before exercise
|
before exercise
|
|
Concentration of CD19+
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of CD19+
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of CD19+
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of CD56+
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of CD56+
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of CD56+
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of CK-MB
Time Frame: before exercise
|
before exercise
|
|
Concentration of CK-MB
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of CK-MB
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of CK-MB
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of TNF-α
Time Frame: before exercise
|
before exercise
|
|
Concentration of TNF-α
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of TNF-α
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of TNF-α
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of IL-8
Time Frame: before exercise
|
before exercise
|
|
Concentration of IL-8
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of IL-8
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of IL-8
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of IL-10
Time Frame: before exercise
|
before exercise
|
|
Concentration of IL-10
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of IL-10
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of IL-10
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of TBARS
Time Frame: before exercise
|
before exercise
|
|
Concentration of TBARS
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of TBARS
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of TBARS
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of PC
Time Frame: before exercise
|
before exercise
|
|
Concentration of PC
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of PC
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of PC
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of SOD
Time Frame: before exercise
|
before exercise
|
|
Concentration of SOD
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of SOD
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of SOD
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of CK
Time Frame: before exercise
|
before exercise
|
|
Concentration of CK
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of CK
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of CK
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of LDH
Time Frame: before exercise
|
before exercise
|
|
Concentration of LDH
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of LDH
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of LDH
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of IL-6
Time Frame: before exercise
|
before exercise
|
|
Concentration of IL-6
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of IL-6
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of IL-6
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of cTnI
Time Frame: before exercise
|
before exercise
|
|
Concentration of cTnI
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of cTnI
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of cTnI
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of eosinophil
Time Frame: before exercise
|
before exercise
|
|
Concentration of eosinophil
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of eosinophil
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of eosinophil
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of basophil
Time Frame: before exercise
|
before exercise
|
|
Concentration of basophil
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of basophil
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of basophil
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of monocyte
Time Frame: before exercise
|
before exercise
|
|
Concentration of monocyte
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of monocyte
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of monocyte
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of lymphocyte
Time Frame: before exercise
|
before exercise
|
|
Concentration of CD56+
Time Frame: before exercise
|
before exercise
|
|
Concentration of NT-proBNP
Time Frame: before exercise
|
before exercise
|
|
Concentration of NT-proBNP
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of NT-proBNP
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of NT-proBNP
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of Testosterone
Time Frame: before exercise
|
before exercise
|
|
Concentration of Testosterone
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of Testosterone
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of Testosterone
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of Cortisol
Time Frame: before exercise
|
before exercise
|
|
Concentration of Cortisol
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of Cortisol
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of Cortisol
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of β-endorphin
Time Frame: before exercise
|
before exercise
|
|
Concentration of β-endorphin
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of β-endorphin
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of β-endorphin
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of Growth hormone
Time Frame: before exercise
|
before exercise
|
|
Concentration of Growth hormone
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of Growth hormone
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of Growth hormone
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of IGF-1
Time Frame: before exercise
|
before exercise
|
|
Concentration of IGF-1
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of IGF-1
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of IGF-1
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of Catalase
Time Frame: before exercise
|
before exercise
|
|
Concentration of Catalase
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of Catalase
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of Catalase
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of IL-15
Time Frame: before exercise
|
before exercise
|
|
Concentration of IL-15
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of IL-15
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of IL-15
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 21, 2022
Primary Completion (Estimated)
February 1, 2024
Study Completion (Estimated)
February 1, 2024
Study Registration Dates
First Submitted
February 20, 2023
First Submitted That Met QC Criteria
March 10, 2023
First Posted (Actual)
March 23, 2023
Study Record Updates
Last Update Posted (Estimated)
December 19, 2023
Last Update Submitted That Met QC Criteria
December 18, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- N202205045
- NSTC111-2410-H-038 -015 (Other Grant/Funding Number: National Science and Technology Council)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.